These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 39085513)

  • 1. Psilocybin desynchronization persists in the human brain.
    Rogers J
    Nat Rev Neurosci; 2024 Sep; 25(9):593. PubMed ID: 39085513
    [No Abstract]   [Full Text] [Related]  

  • 2. Broadband cortical desynchronization underlies the human psychedelic state.
    Muthukumaraswamy SD; Carhart-Harris RL; Moran RJ; Brookes MJ; Williams TM; Errtizoe D; Sessa B; Papadopoulos A; Bolstridge M; Singh KD; Feilding A; Friston KJ; Nutt DJ
    J Neurosci; 2013 Sep; 33(38):15171-83. PubMed ID: 24048847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Significance of the cortical tracings of "sleep" induced in the waking cat by 3 hallucinogens].
    Rougeul A; Verdeaux J; Buser P
    Rev Neurol (Paris); 1966 Jul; 115(1):181-4. PubMed ID: 5956458
    [No Abstract]   [Full Text] [Related]  

  • 4. Neuroimaging: a scanner, colourfully.
    Roiser JP; Rees G
    Curr Biol; 2012 Apr; 22(7):R231-3. PubMed ID: 22497939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Your brain on shrooms - how psilocybin resets neural networks.
    Kozlov M
    Nature; 2024 Jul; 631(8022):721. PubMed ID: 39020195
    [No Abstract]   [Full Text] [Related]  

  • 6. Hallucinogen actions on human brain revealed.
    Lee HM; Roth BL
    Proc Natl Acad Sci U S A; 2012 Feb; 109(6):1820-1. PubMed ID: 22308478
    [No Abstract]   [Full Text] [Related]  

  • 7. Psilocybin--summary of knowledge and new perspectives.
    Tylš F; Páleníček T; Horáček J
    Eur Neuropsychopharmacol; 2014 Mar; 24(3):342-56. PubMed ID: 24444771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Finding the self by losing the self: Neural correlates of ego-dissolution under psilocybin.
    Lebedev AV; Lövdén M; Rosenthal G; Feilding A; Nutt DJ; Carhart-Harris RL
    Hum Brain Mapp; 2015 Aug; 36(8):3137-53. PubMed ID: 26010878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances and challenges in neuroimaging studies on the effects of serotonergic hallucinogens: Contributions of the resting brain.
    Müller F; Liechti ME; Lang UE; Borgwardt S
    Prog Brain Res; 2018; 242():159-177. PubMed ID: 30471679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A psychedelic state arises from desynchronized brain activity.
    Petridis PD
    Nature; 2024 Aug; 632(8023):32-33. PubMed ID: 39020188
    [No Abstract]   [Full Text] [Related]  

  • 11. Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin.
    Carhart-Harris RL; Erritzoe D; Williams T; Stone JM; Reed LJ; Colasanti A; Tyacke RJ; Leech R; Malizia AL; Murphy K; Hobden P; Evans J; Feilding A; Wise RG; Nutt DJ
    Proc Natl Acad Sci U S A; 2012 Feb; 109(6):2138-43. PubMed ID: 22308440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychotomimetic drugs: biochemistry and pharmacology.
    Brimblecombe RW
    Adv Drug Res; 1973; 7():165-206. PubMed ID: 4613150
    [No Abstract]   [Full Text] [Related]  

  • 13. [Action of hallucinogens on electroencephalograms].
    Oughourlian JM; Rougeul A; Verdeaux J
    Therapie; 1971; 26(5):953-68. PubMed ID: 5160349
    [No Abstract]   [Full Text] [Related]  

  • 14. Sixty seconds on . . . psilocybin.
    Hawkes N
    BMJ; 2016 May; 353():i2775. PubMed ID: 27194646
    [No Abstract]   [Full Text] [Related]  

  • 15. Psilocybin disrupts sensory and higher order cognitive processing but not pre-attentive cognitive processing-study on P300 and mismatch negativity in healthy volunteers.
    Bravermanová A; Viktorinová M; Tylš F; Novák T; Androvičová R; Korčák J; Horáček J; Balíková M; Griškova-Bulanova I; Danielová D; Vlček P; Mohr P; Brunovský M; Koudelka V; Páleníček T
    Psychopharmacology (Berl); 2018 Feb; 235(2):491-503. PubMed ID: 29302713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A qualitative report on the subjective experience of intravenous psilocybin administered in an FMRI environment.
    Turton S; Nutt DJ; Carhart-Harris RL
    Curr Drug Abuse Rev; 2014; 7(2):117-27. PubMed ID: 25563444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of serotonin 2A receptors underlies the psilocybin-induced effects on α oscillations, N170 visual-evoked potentials, and visual hallucinations.
    Kometer M; Schmidt A; Jäncke L; Vollenweider FX
    J Neurosci; 2013 Jun; 33(25):10544-51. PubMed ID: 23785166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced repertoire of brain dynamical states during the psychedelic experience.
    Tagliazucchi E; Carhart-Harris R; Leech R; Nutt D; Chialvo DR
    Hum Brain Mapp; 2014 Nov; 35(11):5442-56. PubMed ID: 24989126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bridging Psilocybin-Induced Changes in the Brain's Dynamic Functional Connectome With an Individual's Subjective Experience.
    Singleton SP; Kuceyeski A
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2024 Jul; 9(7):637-638. PubMed ID: 38969436
    [No Abstract]   [Full Text] [Related]  

  • 20. Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels.
    Madsen MK; Fisher PM; Burmester D; Dyssegaard A; Stenbæk DS; Kristiansen S; Johansen SS; Lehel S; Linnet K; Svarer C; Erritzoe D; Ozenne B; Knudsen GM
    Neuropsychopharmacology; 2019 Jun; 44(7):1328-1334. PubMed ID: 30685771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.